COLL·19459J104·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
COLL (COLLEGIUM PHARMACEUTICAL INC) is held by 134 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($169.8M), JANUS HENDERSON GROUP PLC ($60.4M), Invesco Ltd. ($52.6M). Net institutional sentiment: Mixed.
See how COLL's score breaks down across 4 SEC sources
Showing 1-20 of 153
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer